Ufp Technologies (UFPT) Cash from Investing Activities (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Cash from Investing Activities came in at -$1.7 million in Q1 2026, up 40.08% YoY from -$1.2 million in Q1 2025, and up 56.22% on a QoQ basis from -$3.9 million in Q4 2025.
Ufp Technologies (UFPT) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has 17 years of Cash from Investing Activities data on file, last reported at -$1.7 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 40.08% year-over-year to -$1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$26.5 million (up 87.47% YoY) and the FY2025 annual result came in at -$27.6 million, up 86.87% from the prior year.
- Cash from Investing Activities rose to -$1.7 million in Q1 2026, from -$3.9 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $33.4 million in Q3 2022 to a low of -$197.2 million in Q3 2024.
- A 5-year average of -$14.6 million and a median of -$3.0 million in 2022 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities soared 3560.93% — and 2024, when it plunged 6979.61%.
- Tracing UFPT's Cash from Investing Activities over 5 years: stood at -$3.0 million in 2022, then rose by 7.02% to -$2.8 million in 2023, then plunged by 40.93% to -$3.9 million in 2024, then increased by 0.72% to -$3.9 million in 2025, then jumped by 56.22% to -$1.7 million in 2026.
- The last three Cash from Investing Activities figures came in at -$1.7 million (Q1 2026), -$3.9 million (Q4 2025), and -$15.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Ufp Technologies | 2.39 Bn | 2.38 Bn | 50.92 Mn | -1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.10 Mn |
| Jun 30, 2026 | -1.10 Mn |
| Mar 31, 2026 | -1.69 Mn |
| Mar 31, 2026 | -1.69 Mn |
| Dec 31, 2025 | -3.86 Mn |
| Dec 31, 2025 | -3.86 Mn |
| Sep 30, 2025 | -15.27 Mn |
| Sep 30, 2025 | -15.27 Mn |
| Jun 30, 2025 | -5.65 Mn |
| Jun 30, 2025 | -5.65 Mn |
| Mar 31, 2025 | -2.82 Mn |
| Mar 31, 2025 | -2.82 Mn |
| Dec 31, 2024 | -3.88 Mn |
| Dec 31, 2024 | -3.88 Mn |
| Sep 30, 2024 | -197.17 Mn |
| Sep 30, 2024 | -197.17 Mn |
| Jun 30, 2024 | -7.38 Mn |
| Jun 30, 2024 | -7.38 Mn |
| Mar 31, 2024 | -1.73 Mn |
| Mar 31, 2024 | -1.73 Mn |